Literature DB >> 6602264

Lymphocyte cytotoxicity to autologous hepatocytes in alcoholic liver disease.

G Actis, G Mieli-Vergani, B Portmann, A L Eddleston, M Davis, R Williams.   

Abstract

Cytotoxicity of peripheral blood lymphocytes for autologous hepatocytes has been studied in 18 patients with different histological types of alcoholic liver disease. Cytotoxicity was significantly increased in five of ten patients with cirrhosis and/or alcoholic hepatitis but in only one of eight with fatty infiltration or minor histological changes. The cytotoxic effect of T-and non-T-effector cells was separately evaluated in 11 cases. Of six patients with alcoholic hepatitis, non-T lymphocyte cytotoxicity was increased in five and T-cell in only one. These preliminary results are consistent with the concept that autoimmune reactions may play a role in the development and progression of alcoholic hepatitis and cirrhosis, although it is likely that direct hepatotoxic effects of ethanol or its metabolites are also important in determining the pattern of liver injury and perhaps in initiating the immune reactions observed in this study.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6602264     DOI: 10.1111/j.1600-0676.1983.tb00844.x

Source DB:  PubMed          Journal:  Liver        ISSN: 0106-9543


  5 in total

1.  What determines susceptibility to liver damage from alcohol?: discussion paper.

Authors:  J B Saunders; A D Wodak; R Williams
Journal:  J R Soc Med       Date:  1984-03       Impact factor: 5.344

2.  Alcoholic liver disease in the 1980s.

Authors:  J B Saunders
Journal:  Br Med J (Clin Res Ed)       Date:  1983-12-17

3.  Serum antibodies against alcohol-treated rabbit hepatocytes in patients with alcoholic liver disease.

Authors:  N Izumi; C Sato; Y Hasumura; J Takeuchi
Journal:  Clin Exp Immunol       Date:  1985-09       Impact factor: 4.330

4.  Helper and suppressor T lymphocyte function in severe alcoholic liver disease.

Authors:  U McKeever; C O'Mahony; C A Whelan; D G Weir; C Feighery
Journal:  Clin Exp Immunol       Date:  1985-04       Impact factor: 4.330

5.  Interleukin 2 activity in chronic liver disease and the effect of in vitro alpha-interferon.

Authors:  S Saxena; K T Nouri-Aria; M G Anderson; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1986-03       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.